Dr Reddy's Laboratories Ltd
DRREDDY (NSE)

4,393.80

72,436.23
Proj. ROE (%)
16.71
Proj. P/E (x)
21.64
Proj EV / EBITDA (x)
12.61
Proj. P/BV (x)
3.30
Proj. Revenue ( Cr.)
23,527.93

Stock View

BUY
Share on
The average score for Dr Reddy's Laboratories Ltd stands at 8 against 5, three months back.

Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
4,183.52
100 DMA ()
4,183.59
200 DMA ()
4,451.42
52 Weeks Range
3,654.00
5,614.60
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity